Page 72 - 《中国药房》2021年20期
P. 72

强,而游离药物则只能通过细胞膜被动扩散 。由于体                                 cal investigation and determination of CMC values[J]. J
                                              [18]
        外培养的细胞数量和细胞在固定作用时间(4 h)内摄取                               Mater Sci Mater Med,2012,23(4):943-953.
        纳米粒的能力有限,因此在高质量浓度状态下,DTX-                           [ 9 ]  ZHANG T,ZHENG,PENG Q,et al. A novel submicron
        PELGE-NPs 和 DTX 的细胞毒性接近。理论上,在体内                          emulsion system loaded with vincristine-oleic acid ion-
                                                                 pair complex with improved anticancer effect:in vitro and
        环境中,肿瘤细胞处于增殖状态,则可能更有利于
                                                                 in vivo studies[J]. Int J Nanomedicine,2013,8:1185-1196.
        DTX-PELGE-NPs被摄取,但需要进一步实验予以验证。
                                                            [10]  杨立开,何黎黎,段友容,等. mPEG-PLGA-mPEG系列纳
            综上所述,优化所得处方稳定、可行,所得 DTX-
                                                                 米粒的毒性与其结构的关系[J].华西药学杂志,2009,24
        PELGE-NPs粒度均匀,包封率较高,缓释效果明显,体外
                                                                (3):211-214.
        抗肿瘤活性强于DTX注射液。
                                                            [11]  RAO B M,CHAKRABORTY A,SRINIVASU M K,et al.
        参考文献                                                     A stability-indicating HPLC assay method for docetaxel[J].
        [ 1 ]  ZHANG E,XING R,LIU S,et al. Current advances in   J Pharm Biomed Anal,2006,41(2):676-681.
             development of new docetaxel formulations[J]. Expert  [12]  RAWAL M,SINGH A,AMIJI M M. Quality-by-design
             Opin Drug Deliv,2019,16(3):301-312.                 concepts to improve nanotechnology-based drug develop-
        [ 2 ]  FARHAN S M,MUBASHAR R,SHOAIB S H,et al.           ment[J]. Pharm Res,2019,36(11):1-20.
             Advancements in the oral delivery of Docetaxel:chal-  [13]  SHEN S,WU Y,LIU Y,et al. High drug-loading nano-
             lenges,current state-of-the-art and future trends[J]. Int J  medicines:progress,current status,and prospects[J]. Int J
             Nanomedicine,2018,13:3145-3161.                     Nanomedicine,2017,12:4085-4109.
        [ 3 ]  ALKEN S,KELLY C M. Benefit risk assessment and up-  [14]  ROJAS J,PINTO-ALPHANDARY H,LEO E,et al. A
             date on the use of docetaxel in the management of breast  polysorbate-based non-ionic surfactant can modulate loa-
             cancer[J]. Cancer Manag Res,2013,5:357-365.         ding and release of beta-lactoglobulin entrapped in multi-
        [ 4 ]  ALIBOLANDI M,ABNOUS K,HADIZADEH F,et al.          phase poly(DL-lactide-co-glycolide)microspheres[J]. Pharm
             Dextran-poly lactide-co-glycolide polymersomes decorated  Res,1999,16(2):255-260.
             with folate-antennae for targeted delivery of docetaxel to  [15]  DE G,ROSA,AND,et al. Influence of the co-encapsula-
             breast adenocarcinoma in vitro and in vivo[J]. J Control  tion of different non-ionic surfactants on the properties of
             Release,2016,241:45-56.                             PLGA insulin-loaded microspheres[J]. J Controlled Re-
        [ 5 ]  CHEN F,ZHANG J,WANG L,et al. Tumor pH(e)-trig-    lease,2000,69(2):283-295.
             gered charge-reversal and redox-responsive nanoparticles  [16]  LIAO L,ZHANG M,LIU H,et al. Subchronic toxicity
             for docetaxel delivery in hepatocellular carcinoma treat-  and immunotoxicity of MeO-PEG-poly (D,L-lactic-
             ment[J]. Nanoscale,2015,7(38):15763-15779.          co-glycolic acid)-PEG-OMe triblock copolymer nanopar-
        [ 6 ]  AGGARWAL P,HALL J B,MCLELAND C B,et al.           ticles delivered intravenously into rats[J]. Nanotechno-
             Nanoparticle interaction with plasma proteins as it relates  logy,2014,25(24):245705.
             to particle biodistribution,biocompatibility and therapeutic  [17]  LI Y,ZHANG T,LIU Q,et al. PEG-derivatized dual-
             efficacy[J]. Adv Drug Del Rev,2009,61(6):428-437.   functional nanomicelles for improved cancer therapy[J].
        [ 7 ]  CHANG C W,CHOI D,KIM W J,et al. Non-ionic amphi-  Front Pharmacol,2019,10(808):1-15.
             philic biodegradable PEG-PLGA-PEG copolymer enhances  [18]  PHAN Q T,LE M H,LE T,et al. Characteristics and cyto-
             gene delivery efficiency in rat skeletal muscle[J]. J Con-  toxicity of folate-modified curcumin-loaded PLA-PEG
             trolled Release,2007,118(2):245-253.                micellar nano systems with various PLA:PEG ratios[J].
        [ 8 ]  ASHJARI M,KHOEE S,MAHDAVIAN A R,et al.            Int J Pharm,2016,507(1/2):32-40.
             Selfassembled nanomicelles using PLGA-PEG amphiphi-          (收稿日期:2021-05-17  修回日期:2021-09-02)
             lic block copolymer for insulin delivery:a physicochemi-                            (编辑:陈 宏)
















        ·2498 ·  China Pharmacy 2021 Vol. 32 No. 20                                 中国药房    2021年第32卷第20期
   67   68   69   70   71   72   73   74   75   76   77